双膦酸盐在骨转移瘤中的应用进展
摘要点击次数: 1924   全文下载次数: 1343   投稿时间:2007-07-04    
作者Author单位AddressE-Mail
梁鹏 LIANG Peng 甘肃省肿瘤医院骨科,甘肃 兰州 730050 Department of Orthopaedics,the Gansu Cancer Hospital,Lanzhou 730050,Gansu,China liangplz0801@hotmail.com 
期刊信息:《中国骨伤》2008年,第21卷,第6期,第480-482页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
基金项目:
中文摘要:骨转移瘤是肿瘤患者的严重并发症,与骨痛、病理性骨折、神经缺失和(或)高钙血症等紧密相关,因此,骨转移瘤的治疗是必要的。双膦酸盐是标准的治疗和预防骨相关事件的药物,可抑制破骨细胞介导的骨吸收,显示抗癌活性,是最有效的治疗骨转移瘤和预防骨转移并发症的药物,可降低患者骨相关事件的发生,提高患者生活质量。
【关键词】骨肿瘤  肿瘤转移  二膦酸盐类  综述文献
 
The application advances of Bisphosphonates in bone metastasis
ABSTRACT  Bone metastases is a serious complication of patients with tumor. It is associated with substantial morbidity,including bone pain,pathological fracture,neurological deficit and(or) hypercalcemia. Thus,the management of bone metastasis is a clinically significant issue. Bisphosphonates have now become a part of standard therapy to treat and prevent skeletal-related events(SRE),it could inhibit osteoclast-mediated bone resorption and demonstrate antitumor activity in preclinical models. Bisphosphonates are the most effective agent for treating and(or) preventing complications of bone metastasis,reducing the incidence of skeletal-related events,and improving quality of life in patients with bone metastasis.
KEY WORDS  Bone neoplasms  Neoplasm metastasis  Diphosphonates  Review literature
 
引用本文,请按以下格式著录参考文献:
中文格式:梁鹏.双膦酸盐在骨转移瘤中的应用进展[J].中国骨伤,2008,21(6):480~482
英文格式:LIANG Peng.The application advances of Bisphosphonates in bone metastasis[J].zhongguo gu shang / China J Orthop Trauma ,2008,21(6):480~482
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号